AQP2 (E13-21) Antibody sc-47710 from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

AQP2 (E13-21) Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
AQP2 (E13-21) Antibody

Santa Cruz Biotechnology, Inc.'s AQP2 (E13-21) Antibody is a Mouse monoclonal antibody. The AQP2 (E13-21) Antibody was generated using AQP2, and Aquaporin 2 as the antigen. It reacts with Homo Sapiens, Human, Mouse, and Rat. This antibody has been shown to work in applications such as: Precipitation, Immunofluorescence, Immunoprecipitation, and Western Blot.

Description

AQP2 (E13-21)

Product Specs
ItemAQP2 (E13-21) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-47710
Antibody TypePrimary Antibodies
NCBI Gene Aliasescph, aquaporin-2, jpk, AQP-2, AQP-CD, WCH-CD, NDI2
Quantity200 µg/ml
CloneE13-21
ApplicationsWB, IP, IF
Reactivitymouse, rat, human
FormatPurified
Hostmouse
ClonalityMonoclonal
Conjugate/TagUnconjugated
NCBI Full Gene Nameaquaporin 2
TargetAQP2
IsotypeIgM

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) LC3 lipidation is essential for TFEB activation during the lysosomal damage response to kidney injuryNature cell biologyOctober 1, 2020Nakamura S, Shigeyama S, Minami S, Shima T, Akayama S, Matsuda T, Esposito A, Napolitano G, Kuma A, Namba-Hamano T, et al.

(2) Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23Kidney internationalJuly 1, 2018Matsui I, Oka T, Kusunoki Y, Mori D, Hashimoto N, Matsumoto A, Shimada K, Yamaguchi S, Kubota K, Yonemoto S, et al.

(3) Tissue compartment analysis for biomarker discovery by gene expression profilingPloS oneNovember 10, 2009Disset A, Cheval L, Soutourina O, Duong Van Huyen JP, Li G, Genin C, Tostain J, Loupy A, Doucet A, Rajerison R.

(4) Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonatesEndocrinologySeptember 1, 2009Martinerie L, Viengchareun S, Delezoide AL, Jaubert F, Sinico M, Prevot S, Boileau P, Meduri G, Lombès M.

Be the First to Write a Review!